<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38560070</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Enhanced external counterpulsation for management of symptoms associated with long COVID.</ArticleTitle><Pagination><StartPage>100105</StartPage><MedlinePgn>100105</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100105</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2022.100105</ELocationID><Abstract><AbstractText Label="STUDY OBJECTIVE" NlmCategory="UNASSIGNED">Enhanced external counterpulsation (EECP) as a possible therapy for Long COVID.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Retrospective analysis of a contemporary, consecutive patient cohort.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">7 outpatient treatment centers.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">Long COVID patients.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="UNASSIGNED">15-35 EECP treatments.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">The change from baseline in 1) Patient Reported Outcome Measurement Information System (PROMIS) Fatigue; 2) Seattle Angina Questionnaire (SAQ); 3) Duke Activity Status Index (DASI); 4) 6-Minute Walk Test (6MWT); 5) Canadian Cardiovascular Society (CCS) Angina Grade; 6) Rose Dyspnea Scale (RDS); and 7) Patient Health Questionnaire (PHQ-9).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Compared to baseline, the PROMIS Fatigue, SAQ, DASI, and 6MWT improved by 4.63&#xa0;&#xb1;&#xa0;3.42 (p&#xa0;&lt;&#xa0;0.001), 21.44&#xa0;&#xb1;&#xa0;16.54 (p&#xa0;&lt;&#xa0;0.001), 18.08&#xa0;&#xb1;&#xa0;13.82 (p&#xa0;&lt;&#xa0;0.001), and 200.00&#xa0;&#xb1;&#xa0;180.14 (p&#xa0;=&#xa0;0.002), respectively. CCS and RDS improved in 63% and 44% of patients, respectively. All patients unable to work prior to EECP were able to return post-therapy.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">EECP significantly improved validated fatigue and cardiovascular-related markers in patients with Long COVID.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sathyamoorthy</LastName><ForeName>Mohanakrishnan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Texas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verduzco-Gutierrez</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varanasi</LastName><ForeName>Swathi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Flow Therapy, Fort Worth, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Robyn</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Texas Cardiovascular Institute, Fort Worth, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spertus</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Flow Therapy, Fort Worth, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of the Pacific, Stockton, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EECP</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long Haul Syndrome</Keyword><Keyword MajorTopicYN="N">PASC</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Sachin Shah is a consultant and Swathi Varanasi is an employee of Flow Therapy. No other competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>12</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>1</Day><Hour>17</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38560070</ArticleId><ArticleId IdType="pmc">PMC10978164</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2022.100105</ArticleId><ArticleId IdType="pii">S2666-6022(22)00022-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang X., Wang F., Shen Y. Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in Wuhan, China. JAMA Netw. Open. 2021;4(9) doi: 10.1001/jamanetworkopen.2021.27403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021 doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayrit J., Verduzco-Gutierrez M., Teal A., et al. Enhanced external counterpulsation as a novel treatment for post-acute COVID-19 sequelae. Cureus. 2021;13 doi: 10.7759/cureus.14358.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.14358</ArticleId><ArticleId IdType="pmc">PMC8110286</ArticleId><ArticleId IdType="pubmed">33987042</ArticleId></ArticleIdList></Reference><Reference><Citation>Varanasi S., Sathyamoorthy M., Chamakura S., et al. Management of Long-COVID postural orthostatic tachycardia syndrome with enhanced external counterpulsation. Cureus. 2021;13 doi: 10.7759/cureus.18398.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18398</ArticleId><ArticleId IdType="pmc">PMC8555928</ArticleId><ArticleId IdType="pubmed">34729276</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackner M.A., Adams J.A. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg. Top Life Sci. 2020;4:379&#x2013;387. doi: 10.1042/ETLS20200260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/ETLS20200260</ArticleId><ArticleId IdType="pmc">PMC7733673</ArticleId><ArticleId IdType="pubmed">33200786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham K., Gotlieb A. The role of shear stress in the pathogenesis of atherosclerosis. Lab. Investig. 2005;85:9&#x2013;23. doi: 10.1038/labinvest.3700215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3700215</ArticleId><ArticleId IdType="pubmed">15568038</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui J.C.K., Lawson W.E., Barsness G.W. EECP in the treatment of endothelial dysfunction: preventing progression of cardiovascular disease. J. Geriatric Card. 2010;7:79&#x2013;87.</Citation></Reference><Reference><Citation>Braith R.W., Conti R., Nichols W.W., et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010;122:1612&#x2013;1620. doi: 10.1161/CIRCULATIONAHA.109.923482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.923482</ArticleId><ArticleId IdType="pmc">PMC2963100</ArticleId><ArticleId IdType="pubmed">20921442</ArticleId></ArticleIdList></Reference><Reference><Citation>Batysheva T.T., Pivovarchik E.M., Za&#x12d;tsev K.A., et al. The first use of external counterpulsation for the rehabilitation treatment of post-stroke patients. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova. 2009;109:38&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672225</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>